Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

Abstract Background Adult T-cell leukemia lymphoma (ATLL) is a chemotherapy-resistant malignancy with a median survival of less than one year that will afflict between one hundred thousand and one million individuals worldwide who are currently infected with human T-cell leukemia virus type 1. Recur...

Full description

Bibliographic Details
Main Authors: Daniel A. Rauch, Sydney L. Olson, John C. Harding, Hemalatha Sundaramoorthi, Youngsoo Kim, Tianyuan Zhou, A. Robert MacLeod, Grant Challen, Lee Ratner
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Retrovirology
Subjects:
HTLV-1
ATLL
IRF4
Lenalidomide
ASO
Online Access:http://link.springer.com/article/10.1186/s12977-020-00535-z

Internet

http://link.springer.com/article/10.1186/s12977-020-00535-z

Similar Items